Image Plus Consultants Limited (IPCL), a cornerstone in Jamaica’s diagnostic imaging industry, is navigating a challenging financial landscape in the first half of 2024. The company reported a decline in second-quarter revenues by 3.4%, totaling $245.3 million, and a six-month revenue decrease of 2.8% to $539 million compared to the same periods in the previous year. These downturns are primarily attributed to lower scan volumes and various operational difficulties.
A significant development in IPCL’s corporate dynamics is the recent sale of 3.195 million shares by Director Dr. Lilieth Bridgewater. Valued at approximately $5.08 million, this transaction accounts for just over a quarter of a percent of the company’s total shares. Despite this sale, Dr. Bridgewater remains a prominent shareholder, holding a 12.75% stake in the company. She continues to rank among the top three shareholders, alongside Dr. Karlene McDonnough, the board Chairman with a 24.48% share, and Quad G Limited, which holds 16.92%.
IPCL’s financial challenges are compounded by technical issues, including significant downtime of essential diagnostic equipment like CT scanners. The malfunction and eventual retirement of a CT unit at the 129 Old Hope Road branch forced the company to consolidate operations at its Winchester location, placing additional strain on resources and impacting high-margin revenue streams.
In the latest financial disclosures, IPCL reported a net loss of $16.2 million for the second quarter, a stark contrast to the $38.7 million profit recorded in the same period last year. This shift underscores the urgency for the company to adapt and overcome its current obstacles.
Addressing these issues, IPCL has committed to a strategic review aimed at optimizing scan volumes and enhancing operational efficiency. The company is also exploring opportunities for inorganic growth to bolster its market position. Furthermore, plans are underway for the development of the 33LMR facility, which is expected to expand service offerings and create new revenue avenues.
The ownership structure of IPCL remains highly concentrated, with the top 10 shareholders controlling over 82% of the company’s issued capital. This concentration ensures that key stakeholders are closely aligned with the company’s strategic objectives, facilitating coordinated efforts to drive recovery and growth.
Looking forward, IPCL’s leadership is optimistic about a turnaround in the latter half of the fiscal year. By focusing on strategic initiatives and leveraging its robust stakeholder base, the company aims to restore profitability and strengthen its position in Jamaica’s diagnostic imaging sector.
